Management of Clopidogrel (Plavix) in Dental Procedures

Guideline Recommendations

Continue clopidogrel for routine dental extractions, cleanings, and minor oral surgery – the American College of Cardiology, American Heart Association, and American Dental Association joint advisory recommends “little or no indication to interrupt antiplatelet drugs for dental procedures.” [Class I recommendation] 1, 2, 3
Patients on aspirin + clopidogrel may continue both agents for minor dental, eye, or skin procedures – Canadian Cardiovascular Society guideline (Class IIa, Level A for aspirin; Class IIa, Level C for clopidogrel when cardiovascular risk is high). 4, 5, 6

Clinically significant bleeding after dental work is essentially absent – no well‑documented cases of major bleeding in patients taking clopidogrel alone or with aspirin undergoing extractions or other routine procedures. 1, 2, 3
Standard local measures reliably control any minor bleeding – absorbable gelatin sponge, sutures, direct pressure, and tranexamic‑acid mouthwash (2‑4 times daily for 1‑2 days) are sufficient. 1, 2, 3, 7, 4, 5
Once an initial clot forms, recurrent bleeding is unlikely – the same guideline sources confirm durability of the clot. 1, 2

Premature cessation of clopidogrel after recent stent placement markedly raises mortality – in patients undergoing non‑cardiac surgery within 6 weeks of a bare‑metal stent, 6 of 7 who stopped thienopyridine died from presumed stent thrombosis. 3
Early surgery after stent implantation is associated with fatal myocardial infarction when antiplatelet therapy is withheld – 7 patients had MI (6 fatal) within 6 weeks of stent placement; thienopyridine had been stopped in 5 cases. 1

Elective dental or other procedures should be deferred – ≥ 6 weeks after bare‑metal stent (BMS) and ≥ 12 months after drug‑eluting stent (DES). 4, 5, 6, 8, 9
If urgent dental surgery is required within these intervals, continue both aspirin and clopidogrel peri‑operatively – Canadian guideline (Class I, Level B). 4, 5, 6, 8
For routine dental work in stent patients, dual antiplatelet therapy is strongly preferred because interruption carries catastrophic stent‑thrombosis risk. 1, 2, 3

Only for high‑bleeding‑risk procedures (not routine dental work) and when cardiovascular risk is low – Canadian recommendations allow stopping clopidogrel 7‑10 days pre‑procedure if it can be done safely (Class IIb, Level C). 4, 5, 6
Routine dental procedures are classified as low‑bleeding‑risk, so discontinuation is not indicated – reaffirmed by the ACC/AHA/Dental Advisory. 1, 2, 3

Do not instruct patients to stop “blood thinners” before dental procedures without a thorough risk assessment – a common pitfall highlighted by the ACC/AHA advisory. 1, 2, 3
Coordinate any decision to hold clopidogrel with the prescribing cardiologist – guidance from the Gastroenterology Society (Gut 2016). 10
For any routine dental procedure in a patient with a cardiovascular indication (including stents), the default action is to continue clopidogrel – Canadian guideline algorithm. 9
Post‑procedure monitoring – educate patients on expected mild bleeding, provide instructions on when to seek care, and ensure availability of local hemostatic agents. 10

For minor dental procedures (e.g., extractions, cleanings, minor oral surgery), aspirin should be continued without interruption; this is a Class IIa recommendation from the Canadian Cardiovascular Society and is supported by the American College of Chest Physicians 2022 guidelines. 11
Standard local hemostatic measures (absorbable gelatin sponge, sutures, direct pressure, tranexamic‑acid mouthwash) reliably control any minor bleeding that may occur. 12

Discontinuation is only contemplated for procedures with very high bleeding risk (extensive oral surgery, major tissue detachment) and when the patient’s cardiovascular risk is low. 11
If aspirin must be stopped, the drug should be discontinued 7–10 days before the procedure to allow complete platelet turnover. 12

Bare‑Metal Stents (BMS)
- Continue aspirin perioperatively for any dental procedure. 13
- If the dental surgery occurs within 6 weeks of BMS placement, both aspirin and clopidogrel must be continued (Class I, Level B). 11
- Elective dental procedures should be deferred until at least 6 weeks after BMS placement. 14
Drug‑Eluting Stents (DES)
- Maintain aspirin during all dental procedures regardless of timing. 15
- If the procedure is within 12 months of DES placement, both aspirin and clopidogrel must be continued (Class I, Level B). 14
- Elective dental procedures should be deferred until at least 12 months after DES placement. 14

Aspirin should be continued for all dental procedures. 11
Clopidogrel can also be continued for routine dental work (extractions, cleanings). 16
If clopidogrel must be stopped for a high‑bleeding‑risk procedure, it should be discontinued 7–10 days before surgery while aspirin is maintained. 12

Step 1 – Classify Bleeding Risk
- Low‑risk procedures (routine extractions, cleanings, minor oral surgery): continue aspirin. 16
- Very high‑risk procedures (extensive oral surgery, major tissue detachment): proceed to Step 2. 11
Step 2 – Assess Cardiovascular Risk
- High cardiovascular risk (coronary stents, recent MI, stroke, high CHADS₂ score): continue aspirin regardless of bleeding risk. 14
- Low cardiovascular risk and very high bleeding risk: may consider stopping aspirin 7–10 days before the procedure. 11
Step 3 – Stent‑Specific Guidance
- Any stent present → never stop aspirin. 13
- BMS placed < 6 weeks ago → continue aspirin and clopidogrel. 11
- DES placed < 12 months ago → continue aspirin and clopidogrel. 14

Educate patients that mild bleeding is expected and can be managed with local measures (gauze compression for 30–60 minutes).
Tranexamic‑acid mouthwash (2–4 times daily for 1–2 days) effectively controls excessive bleeding after dental procedures. 11
If antiplatelet therapy was interrupted, it should be resumed immediately to avoid increased thrombotic risk. 13